Terrestrial Bio

Terrestrial

Woburn, United States · Founded 2012 · $103.9M raised

Headquarters
Woburn
Founded
2012
Business Model
B2B
Total Funding
$103.9M
Last Round
$50.0M Series CMar 2026
Rounds
5

About

Terrestrial Bio (formerly Vaxess Technologies) has developed a temperature-stable microarray patch (MAP) platform that delivers biologics through the skin without needles, refrigeration, or cold-chain logistics, with a wear time of just five minutes. Its lead program is a once-weekly semaglutide patch for obesity and metabolic disease, pursued via both prescription and Rx-to-OTC pathways. In preclinical studies the patch has shown bioavailability above 80% and pharmacokinetics comparable to subcutaneous injection. The company operates a clinical-grade manufacturing facility in Woburn, Massachusetts and is building a new R&D/manufacturing site in Boston.

Summary

Terrestrial Bio is a Biotech company based in Woburn, United States, founded in 2012. It has raised $103.9M in total across 5 rounds, most recently a $50.0M Series C round in Mar 2026. Investors include RA Capital Management and The Engine.

Tech & App Stack

12 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series CSeries CMar 2026
$50.0M

Sign up to see all 5 rounds

Series A through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Terrestrial Bio on Indexed.vc
<a href="https://indexed.vc/companies/terrestrial-bio"><img src="https://indexed.vc/api/badge/company/terrestrial-bio" alt="Terrestrial Bio on Indexed.vc" width="260" height="76" /></a>